Individualized medicine and the microbiome in reproductive tract

Frontiers in Physiology

Volumn 6, Issue APR, 2015, Pages

  Braundmeier, Andrea G ^a   Lenz, Katherine M ^a   Inman, Kristin S ^b   Chia, Nicholas ^c,d   Jeraldo, Patricio ^c,d   Walther António, Marina R S ^c   Berg Miller, Margret E ^d   Yang, Fang ^d   Creedon, Douglas J ^c   Nelson, Heidi ^c   White, Bryan A ^d  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Biomarkers; Individualized medicine; Microbiome; Pregnancy; Reproductive tract infections

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; PROBIOTIC AGENT;

AMNION FLUID; GENITAL SYSTEM; GENITAL TRACT CANCER; GYNECOLOGIC DISEASE; HIGH THROUGHPUT SEQUENCING; HORMONAL REGULATION; HUMAN; INFECTION; INFERTILITY; INFERTILITY THERAPY; METAGENOME; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROBIOME; NEXT GENERATION SEQUENCING; NONHUMAN; PATHOGENESIS; PELVIC INFLAMMATORY DISEASE; PERSONALIZED MEDICINE; PLACENTA; PREGNANCY; REPRODUCTIVE HEALTH; REVIEW; SEXUALLY TRANSMITTED DISEASE; SYMBIOSIS; UROGENITAL TRACT DISEASE; VAGINITIS;

EID: 84930640751     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00097     Document Type: Review

References (112)

1. Aagaard, K., Ma, J., Antony, K. M., Ganu, R., Petrosino, J., and Versalovic, J. (2014). The placenta harbors a unique microbiome. Sci. Transl. Med. 6, 237ra265. doi: 10.1126/scitranslmed.3008599.
2. Aagaard, K., Riehle, K., Ma, J., Segata, N., Mistretta, T. A., Coarfa, C., et al. (2012). A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS ONE 7:e36466. doi: 10.1371/journal.pone.0036466.
3. Aaltonen, J., Ojala, T., Laitinen, K., Poussa, T., Ozanne, S., and Isolauri, E. (2011). Impact of maternal diet during pregnancy and breastfeeding on infant metabolic programming: a prospective randomized controlled study. Eur. J. Clin. Nutr. 65, 10-19. doi: 10.1038/ejcn.2010.225.
4. Adlercreutz, H., Martin, F., Jarvenpaa, P., and Fotsis, T. (1979). Steroid absorption and enterohepatic recycling. Contraception 20, 201-223. doi: 10.1016/0010-7824(79)90094-5.
5. Antony, K. M., Ma, J., Mitchell, K. B., Racusin, D. A., Versalovic, J., and Aagaard, K. (2014). The preterm placental microbiome varies in association with excess maternal gestational weight gain. Am. J. Obstet. Gynecol. doi: 10.1016/j.ajog.2014.12.041. [Epub ahead of print].
6. Barbonetti, A., Cinque, B., Vassallo, M. R., Mineo, S., Francavilla, S., Cifone, M. G., et al. (2011). Effect of vaginal probiotic lactobacilli on in vitro-induced sperm lipid peroxidation and its impact on sperm motility and viability. Fertil. Steril. 95, 2485-2488. doi: 10.1016/j.fertnstert.2011.03.066.
7. Barrington, J. W., Linton, D., O'Leary, A., Blackwell, A., Brick, J., and Calvert, J. P. (1997). Anaerobic (bacterial) vaginosis and premalignant disease of the cervix. J. Obstet. Gynaecol. 17, 383-385. doi: 10.1080/01443619750112943.
8. Bradshaw, C. S., Morton, A. N., Hocking, J., Garland, S. M., Morris, M. B., Moss, L. M., et al. (2006). High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J. Infect. Dis. 193, 1478-1486. doi: 10.1086/503780.
9. Brocklehurst, P., Gordon, A., Heatley, E., and Milan, S. J. (2013). Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst. Rev. 1:CD000262. doi: 10.1002/14651858.CD000262.
10. Brotman, R. M. (2011). Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J. Clin. Invest. 121, 4610-4617. doi: 10.1172/JCI57172.
11. Brotman, R. M., Erbelding, E. J., Jamshidi, R. M., Klebanoff, M. A., Zenilman, J. M., and Ghanem, K. G. (2007). Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics. J. Pediatr. Adolesc. Gynecol. 20, 225-231. doi: 10.1016/j.jpag.2006.11.009.
12. Brotman, R. M., Klebanoff, M. A., Nansel, T. R., Yu, K. F., Andrews, W. W., Zhang, J., et al. (2010). Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J. Infect. Dis. 202, 1907-1915. doi: 10.1086/657320.
13. Cabrera-Rubio, R., Collado, M. C., Laitinen, K., Salminen, S., Isolauri, E., and Mira, A. (2012). The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am. J. Clin. Nutr. 96, 544-551. doi: 10.3945/ajcn.112.037382.
14. Cai, J. L., Qin, L. H., and Hu, Z. Y. (2010). [The development of systematic evolution of ligands by exponential enrichment in tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 33, 210-211.
15. Centers for Disease Control Prevention Workowski, K. A., and Berman, S. M. (2006). Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm. Rep. 55, 1-94.
16. Chung, H., Pamp, S. J., Hill, J. A., Surana, N. K., Edelman, S. M., Troy, E. B., et al. (2012). Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149, 1578-1593. doi: 10.1016/j.cell.2012.04.037.
17. Cole, C. B., Fuller, R., Mallet, A. K., and Rowland, I. R. (1985). The influence of the host on expression of intestinal microbial enzyme activities involved in metabolism of foreign compounds. J. Appl. Bacteriol. 59, 549-553. doi: 10.1111/j.1365-2672.1985.tb03359.x.
18. Costello, E. K., Lauber, C. L., Hamady, M., Fierer, N., Gordon, J. I., and Knight, R. (2009). Bacterial community variation in human body habitats across space and time. Science 326, 1694-1697. doi: 10.1126/science.1177486.
19. Dabek, M., McCrae, S. I., Stevens, V. J., Duncan, S. H., and Louis, P. (2008). Distribution of beta-glucosidase and beta-glucuronidase activity and of beta-glucuronidase gene gus in human colonic bacteria. FEMS Microbiol. Ecol. 66, 487-495. doi: 10.1111/j.1574-6941.2008.00520.x.
20. Dechen, T. C., Sumit, K., and Ranabir, P. (2010). Correlates of vaginal colonization with group B streptococci among pregnant women. J. Glob. Infect. Dis. 2, 236-241. doi: 10.4103/0974-777X.68536.
21. Decker, E., Hornef, M., and Stockinger, S. (2011). Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children. Gut. Microbes. 2, 91-98. doi: 10.4161/gmic.2.2.15414.
22. Denslow, S. A., Westreich, D. J., Firnhaber, C., Michelow, P., Williams, S., and Smith, J. S. (2011). Bacterial vaginosis as a risk factor for high-grade cervical lesions and cancer in HIV-seropositive women. Int. J. Gynaecol. Obstet. 114, 273-277. doi: 10.1016/j.ijgo.2011.03.011.
23. Dielubanza, E. J., and Schaeffer, A. J. (2011). Urinary tract infections in women. Med. Clin. North Am. 95, 27-41. doi: 10.1016/j.mcna.2010.08.023.
24. DiGiulio, D. B. (2012). Diversity of microbes in amniotic fluid. Semin. Fetal. Neonatal. Med. 17, 2-11. doi: 10.1016/j.siny.2011.10.001.
25. Dominguez, F., Galan, A., Martin, J. J., Remohi, J., Pellicer, A., and Simon, C. (2003). Hormonal and embryonic regulation of chemokine receptors CXCR1, CXCR4, CCR5 and CCR2B in the human endometrium and the human blastocyst. Mol. Hum. Reprod. 9, 189-198. doi: 10.1093/molehr/gag024.
26. Donders, G. (2010). Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review. Obstet. Gynecol. Surv. 65, 462-473. doi: 10.1097/OGX.0b013e3181e09621.
27. Donders, G. G., Van Bulck, B., Van de Walle, P., Kaiser, R. R., Pohlig, G., Gonser, S., et al. (2010). Effect of lyophilized lactobacilli and 0.03 mg estriol (Gynoflor(R)) on vaginitis and vaginosis with disrupted vaginal microflora: a multicenter, randomized, single-blind, active-controlled pilot study. Gynecol. Obstet. Invest. 70, 264-272. doi: 10.1159/000314016.
28. Douvier, S., Neuwirth, C., Filipuzzi, L., and Kisterman, J. P. (1999). Chorioamnionitis with intact membranes caused by Capnocytophaga sputigena. Eur. J. Obstet. Gynecol. Reprod. Biol. 83, 109-112. doi: 10.1016/S0301-2115(98)00240-1.
29. Doyle, R. M., Alber, D. G., Jones, H. E., Harris, K., Fitzgerald, F., Peebles, D., et al. (2014). Term and preterm labour are associated with distinct microbial community structures in placental membranes which are independent of mode of delivery. Placenta 35, 1099-1101. doi: 10.1016/j.placenta.2014.10.007.
30. Drell, T., Lillsaar, T., Tummeleht, L., Simm, J., Aaspollu, A., Vain, E., et al. (2013). Characterization of the vaginal micro-and mycobiome in asymptomatic reproductive-age Estonian women. PLoS ONE 8:e54379. doi: 10.1371/journal.pone.0054379.
31. Egbase, P. E., al-Sharhan, M., al-Othman, S., al-Mutawa, M., Udo, E. E., and Grudzinskas, J. G. (1996). Incidence of microbial growth from the tip of the embryo transfer catheter after embryo transfer in relation to clinical pregnancy rate following in-vitro fertilization and embryo transfer. Hum. Reprod. 11, 1687-1689. doi: 10.1093/oxfordjournals.humrep.a019470.
32. Egbase, P. E., Udo, E. E., Al-Sharhan, M., and Grudzinskas, J. G. (1999). Prophylactic antibiotics and endocervical microbial inoculation of the endometrium at embryo transfer. Lancet 354, 651-652. doi: 10.1016/S0140-6736(99)02415-0.
33. Fanca-Berthon, P., Hoebler, C., Mouzet, E., David, A., and Michel, C. (2010). Intrauterine growth restriction not only modifies the cecocolonic microbiota in neonatal rats but also affects its activity in young adult rats. J. Pediatr. Gastroenterol. Nutr. 51, 402-413. doi: 10.1097/MPG.0b013e3181d75d52.
34. Fanchin, R., Harmas, A., Benaoudia, F., Lundkvist, U., Olivennes, F., and Frydman, R. (1998). Microbial flora of the cervix assessed at the time of embryo transfer adversely affects in vitro fertilization outcome. Fertil. Steril. 70, 866-870. doi: 10.1016/S0015-0282(98)00277-5.
35. Fardini, Y., Chung, P., Dumm, R., Joshi, N., and Han, Y. W. (2010). Transmission of diverse oral bacteria to murine placenta: evidence for the oral microbiome as a potential source of intrauterine infection. Infect. Immun. 78, 1789-1796. doi: 10.1128/IAI.01395-09.
36. Fichorova, R. N., Yamamoto, H. S., Delaney, M. L., Onderdonk, A. B., and Doncel, G. F. (2011). Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. MBio 2, e00168-e00111. doi: 10.1128/mBio.00168-11.
37. Filicori, M., Flamigni, C., Meriggiola, M. C., Ferrari, P., Michelacci, L., Campaniello, E., et al. (1991). Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders. J. Clin. Endocrinol. Metab. 72, 965-972. doi: 10.1210/jcem-72-5-965.
38. Fredericks, D. N., and Relman, D. A. (1996). Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin. Microbiol. Rev. 9, 18-33.
39. Fredricks, D. N., Fiedler, T. L., and Marrazzo, J. M. (2005). Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 353, 1899-1911. doi: 10.1056/NEJMoa043802.
40. Gadelle, D., Raibaud, P., and Sacquet, E. (1985). beta-Glucuronidase activities of intestinal bacteria determined both in vitro and in vivo in gnotobiotic rats. Appl. Environ. Microbiol. 49, 682-685.
41. Gajer, P., Brotman, R. M., Bai, G., Sakamoto, J., Schutte, U. M., Zhong, X., et al. (2012). Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 4, 132ra152. doi: 10.1126/scitranslmed.3003605.
42. Gautray, J. P., de Brux, J., Tajchner, G., Robel, P., and Mouren, M. (1981). Clinical investigation of the menstrual cycle. III. Clinical, endometrial, and endocrine aspects of luteal defect. Fertil. Steril. 35, 296-303.
43. Gillet, E., Meys, J. F., Verstraelen, H., Verhelst, R., De Sutter, P., Temmerman, M., et al. (2012). Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and meta-analysis. PLoS ONE 7:e45201. doi: 10.1371/journal.pone.0045201.
44. Groeger, D., O'Mahony, L., Murphy, E. F., Bourke, J. F., Dinan, T. G., Kiely, B., et al. (2013). Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut. Microbes. 4, 325-339. doi: 10.4161/gmic.25487.
45. Gronlund, M. M., Gueimonde, M., Laitinen, K., Kociubinski, G., Gronroos, T., Salminen, S., et al. (2007). Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin. Exp. Allergy. 37, 1764-1772. doi: 10.1111/j.1365-2222.2007.02849.x.
46. Guarino, A., Wudy, A., Basile, F., Ruberto, E., and Buccigrossi, V. (2012). Composition and roles of intestinal microbiota in children. J. Matern. Fetal. Neonatal. Med. 25(Suppl. 1), 63-66. doi: 10.3109/14767058.2012.663231.
47. Guijon, F., Paraskevas, M., Rand, F., Heywood, E., Brunham, R., and McNicol, P. (1992). Vaginal microbial flora as a cofactor in the pathogenesis of uterine cervical intraepithelial neoplasia. Int. J. Gynaecol. Obstet. 37, 185-191. doi: 10.1016/0020-7292(92)90379-W.
48. Gupta, M., McDougal, A., and Safe, S. (1998). Estrogenic and antiestrogenic activities of 16alpha-and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells. J. Steroid. Biochem. Mol. Biol. 67, 413-419. doi: 10.1016/S0960-0760(98)00135-6.
49. Han, Y. W., Ikegami, A., Bissada, N. F., Herbst, M., Redline, R. W., and Ashmead, G. G. (2006). Transmission of an uncultivated Bergeyella strain from the oral cavity to amniotic fluid in a case of preterm birth. J. Clin. Microbiol. 44, 1475-1483. doi: 10.1128/JCM.44.4.1475-1483.2006.
50. Han, Y. W., Redline, R. W., Li, M., Yin, L., Hill, G. B., and McCormick, T. S. (2004). Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect. Immun. 72, 2272-2279. doi: 10.1128/IAI.72.4.2272-2279.2004.
51. Han, Y. W., Shen, T., Chung, P., Buhimschi, I. A., and Buhimschi, C. S. (2009). Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. J. Clin. Microbiol. 47, 38-47. doi: 10.1128/JCM.01206-08.
52. Harris, J., and Brown, H. (1927). Bacterial content of the uterus at cesarean secion. Am. J. Obstet. Gynecol. 13, 133.
53. Hickey, D. K., Patel, M. V., Fahey, J. V., and Wira, C. R. (2011). Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J. Reprod. Immunol. 88, 185-194. doi: 10.1016/j.jri.2011.01.005.
54. Hickey, R. J., Abdo, Z., Zhou, X., Nemeth, K., Hansmann, M., Osborn, T. W. III, et al. (2013). Effects of tampons and menses on the composition and diversity of vaginal microbial communities over time. BJOG 120, 695-704. doi: 10.1111/1471-0528.12151.
55. Hill, G. B. (1998). Preterm birth: associations with genital and possibly oral microflora. Ann. Periodontol. 3, 222-232. doi: 10.1902/annals.1998.3.1.222.
56. Hill, J. A., and Anderson, D. J. (1992). Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions. Am. J. Obstet. Gynecol. 166, 720-726. doi: 10.1016/0002-9378(92)91703-D.
57. Hou, D., Zhou, X., Zhong, X., Settles, M. L., Herring, J., Wang, L., et al. (2013). Microbiota of the seminal fluid from healthy and infertile men. Fertil. Steril. 100, 1261-1269. doi: 10.1016/j.fertnstert.2013.07.1991.
58. Human Microbiome Jumpstart Reference Strains Consortium, Nelson, K. E., Weinstock, G. M., Highlander, S. K., Worley, K. C., Creasy, H. H., et al. (2010). A catalog of reference genomes from the human microbiome. Science 328, 994-999. doi: 10.1126/science.1183605.
59. Human Microbiome Project Consortium (2012a). Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214. doi: 10.1038/nature11234.
60. Human Microbiome Project Consortium. (2012b). A framework for human microbiome research. Nature 486, 215-221. doi: 10.1038/nature11209.
61. Huurre, A., Kalliomaki, M., Rautava, S., Rinne, M., Salminen, S., and Isolauri, E. (2008). Mode of delivery-effects on gut microbiota and humoral immunity. Neonatology 93, 236-240. doi: 10.1159/000111102.
62. Hyman, R. W., Fukushima, M., Jiang, H., Fung, E., Rand, L., Johnson, B., et al. (2013). Diversity of the vaginal microbiome correlates with preterm birth. Reprod. Sci. 21, 32-40. doi: 10.1177/1933719113488838.
63. Hyman, R. W., Herndon, C. N., Jiang, H., Palm, C., Fukushima, M., Bernstein, D., et al. (2012). The dynamics of the vaginal microbiome during infertility therapy with in vitro fertilization-embryo transfer. J. Assist. Reprod. Genet. 29, 105-115. doi: 10.1007/s10815-011-9694-6.
64. Jaiyeoba, O., Lazenby, G., and Soper, D. E. (2011). Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert. Rev. Anti. Infect. Ther. 9, 61-70. doi: 10.1586/eri.10.156.
65. Kabat, G. C., Chang, C. J., Sparano, J. A., Sepkovie, D. W., Hu, X. P., Khalil, A., et al. (1997). Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol. Biomarkers Prev. 6, 505-509.
66. Kaul, R., Pettengell, C., Sheth, P. M., Sunderji, S., Biringer, A., MacDonald, K., et al. (2008). The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. J. Reprod. Immunol. 77, 32-40. doi: 10.1016/j.jri.2007.02.002.
67. Kaushic, C. (2009). The role of the local microenvironment in regulating susceptibility and immune responses to sexually transmitted viruses in the female genital tract. J. Reprod. Immunol. 83, 168-172. doi: 10.1016/j.jri.2009.08.010.
68. Kim, Y. G., Ohta, T., Takahashi, T., Kushiro, A., Nomoto, K., Yokokura, T., et al. (2006). Probiotic Lactobacillus casei activates innate immunity via NF-kappaB and p38 MAP kinase signaling pathways. Microbes. Infect. 8, 994-1005. doi: 10.1016/j.micinf.2005.10.019.
69. Klebanoff, S. J., and Coombs, R. W. (1991). Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J. Exp. Med. 174, 289-292. doi: 10.1084/jem.174.1.289.
70. Ley, R. E., Knight, R., and Gordon, J. I. (2007). The human microbiome: eliminating the biomedical/environmental dichotomy in microbial ecology. Environ. Microbiol. 9, 3-4. doi: 10.1111/j.1462-2920.2006.01222_3.x.
71. Ley, R. E., Peterson, D. A., and Gordon, J. I. (2006). Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124, 837-848. doi: 10.1016/j.cell.2006.02.017.
72. Ling, Z., Liu, X., Chen, W., Luo, Y., Yuan, L., Xia, Y., et al. (2013). The restoration of the vaginal microbiota after treatment for bacterial vaginosis with metronidazole or probiotics. Microb. Ecol. 65, 773-780. doi: 10.1007/s00248-012-0154-3.
73. Liversedge, N. H., Turner, A., Horner, P. J., Keay, S. D., Jenkins, J. M., and Hull, M. G. (1999). The influence of bacterial vaginosis on in-vitro fertilization and embryo implantation during assisted reproduction treatment. Hum. Reprod. 14, 2411-2415. doi: 10.1093/humrep/14.9.2411.
74. Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., and Knight, R. (2012). Diversity, stability and resilience of the human gut microbiota. Nature 489, 220-230. doi: 10.1038/nature11550.
75. Luthje, P., Hirschberg, A. L., and Brauner, A. (2014). Estrogenic action on innate defense mechanisms in the urinary tract. Maturitas 77, 32-36. doi: 10.1016/j.maturitas.2013.10.018.
76. Ma, B., Forney, L. J., and Ravel, J. (2012). Vaginal microbiome: rethinking health and disease. Annu. Rev. Microbiol. 66, 371-389. doi: 10.1146/annurev-micro-092611-150157.
77. Makino, H., Kushiro, A., Ishikawa, E., Kubota, H., Gawad, A., Sakai, T., et al. (2013). Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant's microbiota. PLoS ONE 8:e78331. doi: 10.1371/journal.pone.0078331.
78. Mandar, R. (2013). Microbiota of male genital tract: impact on the health of man and his partner. Pharmacol. Res. 69, 32-41. doi: 10.1016/j.phrs.2012.10.019.
79. Manichanh, C., Varela, E., Martinez, C., Antolin, M., Llopis, M., Dore, J., et al. (2008). The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am. J. Gastroenterol. 103, 1754-1761. doi: 10.1111/j.1572-0241.2008.01868.x.
80. Mardis, E. R. (2008). Next-generation DNA sequencing methods. Annu. Rev. Genomics Hum. Genet. 9, 387-402. doi: 10.1146/annurev.genom.9.081307.164359.
81. Martin, H. L., Richardson, B. A., Nyange, P. M., Lavreys, L., Hillier, S. L., Chohan, B., et al. (1999). Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180, 1863-1868. doi: 10.1086/315127.
82. Mendz, G. L., Kaakoush, N. O., and Quinlivan, J. A. (2013). Bacterial aetiological agents of intra-amniotic infections and preterm birth in pregnant women. Front. Cell Infect. Microbiol. 3:58. doi: 10.3389/fcimb.2013.00058.
83. Mirmonsef, P., Gilbert, D., Zariffard, M. R., Hamaker, B. R., Kaur, A., Landay, A. L., et al. (2011). The effects of commensal bacteria on innate immune responses in the female genital tract. Am. J. Reprod. Immunol. 65, 190-195. doi: 10.1111/j.1600-0897.2010.00943.x.
84. Ness, R. B., Hillier, S. L., Richter, H. E., Soper, D. E., Stamm, C., McGregor, J., et al. (2002). Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet. Gynecol. 100, 765. doi: 10.1016/S0029-7844(02)02184-1.
85. Nicol, A. F., Fernandes, A. T., and Bonecini-Almei da Mda, G. (2005). Immune response in cervical dysplasia induced by human papillomavirus: the influence of human immunodeficiency virus-1 co-infection-review. Mem. Inst. Oswaldo. Cruz. 100, 1-12. doi: 10.1590/S0074-02762005000100001.
86. Obst, J. M., and Seamark, R. F. (1975). Hormone studies on ewes grazing an oestrogenic (Yarloop clover) pasture during the reproductive cycle. Aust. J. Biol. Sci. 28, 279-290.
87. Parkin, D. M. (2006). The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118, 3030-3044. doi: 10.1002/ijc.21731.
88. Payne, M. S., and Bayatibojakhi, S. (2014). Exploring preterm birth as a polymicrobial disease: an overview of the uterine microbiome. Front. Immunol. 5:595. doi: 10.3389/fimmu.2014.00595.
89. Petricevic, L., Domig, K. J., Nierscher, F. J., Sandhofer, M. J., Fidesser, M., Krondorfer, I., et al. (2014). Characterisation of the vaginal Lactobacillus microbiota associated with preterm delivery. Sci. Rep. 4, 5136. doi: 10.1038/srep05136.
90. Platz-Christensen, J. J., Sundstrom, E., and Larsson, P. G. (1994). Bacterial vaginosis and cervical intraepithelial neoplasia. Acta Obstet. Gynecol. Scand. 73, 586-588. doi: 10.3109/00016349409006278.
91. Plottel, C. S., and Blaser, M. J. (2011). Microbiome and malignancy. Cell Host. Microbe. 10, 324-335. doi: 10.1016/j.chom.2011.10.003.
92. Quan, M. (2010). Vaginitis: diagnosis and management. Postgrad. Med. 122, 117-127. doi: 10.3810/pgm.2010.11.2229.
93. Ravel, J., Gajer, P., Abdo, Z., Schneider, G. M., Koenig, S. S., McCulle, S. L., et al. (2011). Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. U.S.A. 108, 4680-4687. doi: 10.1073/pnas.1002611107.
94. Reid, G., Burton, J., and Devillard, E. (2004). The rationale for probiotics in female urogenital healthcare. MedGenMed 6, 49.
95. Reid, J. N., Bisanz, J. E., Monachese, M., Burton, J. P., and Reid, G. (2013). The rationale for probiotics improving reproductive health and pregnancy outcome. Am. J. Reprod. Immunol. 69, 558-566. doi: 10.1111/aji.12086.
96. Rifkin, S. B., Smith, M. R., Brotman, R. M., Gindi, R. M., and Erbelding, E. J. (2009). Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore, MD. Contraception 80, 63-67. doi: 10.1016/j.contraception.2009.01.008.
97. Roger, L. C., Costabile, A., Holland, D. T., Hoyles, L., and McCartney, A. L. (2010). Examination of faecal Bifidobacterium populations in breast-and formula-fed infants during the first 18 months of life. Microbiology 156, 3329-3341. doi: 10.1099/mic.0.043224-0.
98. Round, J. L., and Mazmanian, S. K. (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313-323. doi: 10.1038/nri2515.
99. Sartor, R. B. (2004). Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126, 1620-1633. doi: 10.1053/j.gastro.2004.03.024.
100. Satokari, R., Gronroos, T., Laitinen, K., Salminen, S., and Isolauri, E. (2009). Bifidobacterium and Lactobacillus DNA in the human placenta. Lett. Appl. Microbiol. 48, 8-12. doi: 10.1111/j.1472-765X.2008.02475.x.
101. Sha, B. E., Zariffard, M. R., Wang, Q. J., Chen, H. Y., Bremer, J., Cohen, M. H., et al. (2005). Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J. Infect. Dis. 191, 25-32. doi: 10.1086/426394.
102. Sirota, I., Zarek, S. M., and Segars, J. H. (2014). Potential influence of the microbiome on infertility and assisted reproductive technology. Semin. Reprod. Med. 32, 35-42. doi: 10.1055/s-0033-1361821.
103. Taylor, B. D., Darville, T., and Haggerty, C. L. (2013). Does bacterial vaginosis cause pelvic inflammatory disease? Sex Transm. Dis. 40, 117-122. doi: 10.1097/OLQ.0b013e31827c5a5b.
104. Tojo, R., Suarez, A., Clemente, M. G., de los Reyes-Gavilan, C. G., Margolles, A., Gueimonde, M., et al. (2014). Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J. Gastroenterol. 20 15163-15176. doi: 10.3748/wjg.v20.i41.15163.
105. Tringe, S. G., von Mering, C., Kobayashi, A., Salamov, A. A., Chen, K., Chang, H. W., et al. (2005). Comparative metagenomics of microbial communities. Science 308, 554-557. doi: 10.1126/science.1107851.
106. van Oostrum, N., De Sutter, P., Meys, J., and Verstraelen, H. (2013). Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis. Hum. Reprod. 28, 1809-1815. doi: 10.1093/humrep/det096.
107. Vassallo, M. F., and Walker, W. A. (2008). Neonatal microbial flora and disease outcome. Nestle Nutr. Workshop Ser. Pediatr. Program. 61, 211-224. doi: 10.1159/000113496.
108. Vitali, B., Cruciani, F., Baldassarre, M. E., Capursi, T., Spisni, E., Valerii, M. C., et al. (2012). Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion. BMC Microbiol. 12:236. doi: 10.1186/1471-2180-12-236.
109. Walther-Antonio, M. R., Jeraldo, P., Berg Miller, M. E., Yeoman, C. J., Nelson, K. E., Wilson, B. A., et al. (2014). Pregnancy's stronghold on the vaginal microbiome. PLoS ONE 9:e98514. doi: 10.1371/journal.pone.0098514.
110. Witkin, S. S., Kligman, I., Grifo, J. A., and Rosenwaks, Z. (1995). Chlamydia trachomatis detected by polymerase chain reaction in cervices of culture-negative women correlates with adverse in vitro fertilization outcome. J. Infect. Dis. 171, 1657-1659. doi: 10.1093/infdis/171.6.1657.
111. Yarbrough, V. L., Winkle, S., and Herbst-Kralovetz, M. M. (2014). Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications. Hum. Reprod. Update doi: 10.1093/humupd/dmu065. [Epub ahead of print].
112. Yeoman, C. J., Thomas, S. M., Miller, M. E., Ulanov, A. V., Torralba, M., Lucas, S., et al. (2013). A multi-omic systems-based approach reveals metabolic markers of bacterial vaginosis and insight into the disease. PLoS ONE 8:e56111. doi: 10.1371/journal.pone.0056111.